17 results
A1C and eAG
~
*For Educational Purposes Only*

#Diabetes #T2D #DM2 #Table #PrimaryCare #Endocrinology #BloodGlucose #A1C
#Diabetes #T2D ... #DM2 #Table #PrimaryCare
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
lowered CV events in T2DM ... lowered CV events in T2DM ... events in CKD + T2DM ... with or without T2DM ... visualabstract #table
Adverse Effects of Antipsychotic Medications - Comparison Table

First Generation: chlopromazine, haloperidol, fluphenazine 
Second Generation: aripirazole, asenapine,
Medications - Comparison Table ... Side Effects: EPS/TD ... Dyslipidemia, Weight Gain/T2DM ... Profiles #Comparison #Table
Type 2 Diabetes handout for patients. 
#diabetes #t2d #dm2 #low carb diet #HA1C #patient education #endocrinology
#diabetes #t2d # ... dm2 #low carb diet
IDSA Algorithm for the Initial Management of Fever and Neutropenia

LOW RISK
 • Antidpated neutropenia < 7
IDSA Algorithm for ... and clinically stable ... neutropenic #fever #IDSA ... #Algorithm #Management
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
patients with T2D ... mL/minute/1.73 m2 ... Pharmacology #Summary #DM2
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Ozempic), or daily tablet ... patients with T2D ... Pharmacology #Summary #DM2
The “twin cycles” of diabetes, first introduced by Roy Taylor in 2008.  
#fatty liver #fatty
pancreas #diabetes #t2d ... #dm2 #insulin resistance
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Sulfonylurea, TZD ... Diabetes #Mellitus #DM2 ... pharmacology #comparison #table
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
patients with T2D ... ml/min per 1.73 m2